These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15335146)

  • 1. Chronic inflammation in peritoneal dialysis: the search for the holy grail?
    Pecoits-Filho R; Stenvinkel P; Wang AY; Heimbürger O; Lindholm B
    Perit Dial Int; 2004; 24(4):327-39. PubMed ID: 15335146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling inflammation in peritoneal dialysis: the role of pd-related factors as potential intervention targets.
    Fortes PC; Versari PH; Stinghen AE; Pecoits-Filho R
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S76-81. PubMed ID: 17556335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients.
    Yong K; Dogra G; Boudville N; Lim W
    Perit Dial Int; 2018; 38(1):18-23. PubMed ID: 29097485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Being an inflamed peritoneal dialysis patient - a Dante's journey.
    Carrero JJ; Axelsson J; Avesani CM; Heimbürger O; Lindholm B; Stenvinkel P
    Contrib Nephrol; 2006; 150():144-151. PubMed ID: 16721004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation in peritoneal dialysis: a Latin-American perspective.
    Cueto-Manzano AM; González-Espinoza L; Martin del Campo F; Fortes PC; Pecoits-Filho R
    Perit Dial Int; 2007; 27(3):347-52. PubMed ID: 17468489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of chronic inflammation in peritoneal dialysis.
    Wang AY
    Semin Nephrol; 2011 Mar; 31(2):159-71. PubMed ID: 21439430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-related systemic microinflammation is associated with specific genomic patterns.
    Zaza G; Pontrelli P; Pertosa G; Granata S; Rossini M; Porreca S; Staal FJ; Gesualdo L; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 2008 May; 23(5):1673-81. PubMed ID: 18048420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and local inflammation in peritoneal dialysis: mechanisms, biomarkers and effects on outcome.
    Cordeiro AC; Carrero JJ; Abensur H; Lindholm B; Stenvinkel P
    Contrib Nephrol; 2009; 163():132-139. PubMed ID: 19494606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences.
    Yao Q; Axelsson J; Heimburger O; Stenvinkel P; Lindholm B
    Minerva Urol Nefrol; 2004 Sep; 56(3):237-48. PubMed ID: 15467502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and nutrition in renal insufficiency.
    Kalantar-Zadeh K; Stenvinkel P; Pillon L; Kopple JD
    Adv Ren Replace Ther; 2003 Jul; 10(3):155-69. PubMed ID: 14708070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients.
    Zoccali C; Enia G; Tripepi G; Panuccio V; Mallamaci F
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S84-7. PubMed ID: 16048265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy.
    Herget-Rosenthal S; Klein T; Marggraf G; Hirsch T; Jakob HG; Philipp T; Kribben A
    Scand J Immunol; 2005 Feb; 61(2):180-6. PubMed ID: 15683455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients.
    Koo HM; Do HM; Kim EJ; Lee MJ; Shin DH; Kim SJ; Oh HJ; Yoo DE; Kim JK; Park JT; Han SH; Kang SW; Choi KH; Yoo TH
    Atherosclerosis; 2011 Dec; 219(2):925-30. PubMed ID: 22015178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
    Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of inflammation before and during peritoneal dialysis.
    Palomar-Fontanet R; Lavin-Gómez BA; Quintanar-Lartundo JA; García-Unzueta MT; Gago-Fraile M; Torrealba-Rodríguez MI; Arias-Rodriguez MA; Gómez-Gerique JA
    Adv Perit Dial; 2011; 27():28-32. PubMed ID: 22073824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis.
    Lam MF; Leung JC; Lam CW; Tse KC; Lo WK; Lui SL; Chan TM; Tam S; Lai KN
    Perit Dial Int; 2008; 28(4):377-84. PubMed ID: 18556380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins for treatment of dyslipidemia in chronic kidney disease.
    Shurraw S; Tonelli M
    Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.